← Open Payments lookup

CARYN ECKER: Open Payments

NPI 1427351063 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,125 in 48 payments from 23 companies in 2025. Trend: 2023 $874 · 2024 $1,695 · 2025 $1,125

Food & beverage: $1,026Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.4$191
Celgene Corporation8$157
PFIZER INC.5$102
ARRAY BIOPHARMA INC4$73
AstraZeneca Pharmaceuticals LP3$66
Gilead Sciences, Inc.2$61
Rigel Pharmaceuticals, Inc.2$52
ABBVIE INC.2$49
E.R. Squibb & Sons, L.L.C.2$41
GENZYME CORPORATION1$35

Products named: REBLOZYL, RYBREVANT, OPDIVO, BOSULIF, Trodelvy, DARZALEX, TAVALISSE, BRAFTOVI.

Industry payments across NY — which companies pay providers there.